162 related articles for article (PubMed ID: 26293519)
1. Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin.
Reuter SE; Evans AM; Shakib S; Lungershausen Y; Francis B; Valentini G; Bacchieri A; Ubben D; Pace S
Clin Drug Investig; 2015 Sep; 35(9):559-67. PubMed ID: 26293519
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
Green JA; Mohamed K; Goyal N; Bouhired S; Hussaini A; Jones SW; Koh GC; Kostov I; Taylor M; Wolstenholm A; Duparc S
Antimicrob Agents Chemother; 2016 Dec; 60(12):7321-7332. PubMed ID: 27697758
[TBL] [Abstract][Full Text] [Related]
3. Open-label crossover study of primaquine and dihydroartemisinin-piperaquine pharmacokinetics in healthy adult thai subjects.
Hanboonkunupakarn B; Ashley EA; Jittamala P; Tarning J; Pukrittayakamee S; Hanpithakpong W; Chotsiri P; Wattanakul T; Panapipat S; Lee SJ; Day NP; White NJ
Antimicrob Agents Chemother; 2014 Dec; 58(12):7340-6. PubMed ID: 25267661
[TBL] [Abstract][Full Text] [Related]
4. The influence of food on the pharmacokinetics of piperaquine in healthy Vietnamese volunteers.
Hai TN; Hietala SF; Van Huong N; Ashton M
Acta Trop; 2008 Aug; 107(2):145-9. PubMed ID: 18585670
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women.
Benjamin JM; Moore BR; Salman S; Page-Sharp M; Tawat S; Yadi G; Lorry L; Siba PM; Batty KT; Robinson LJ; Mueller I; Davis TM
Antimicrob Agents Chemother; 2015 Jul; 59(7):4260-71. PubMed ID: 25963981
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
Rijken MJ; McGready R; Phyo AP; Lindegardh N; Tarning J; Laochan N; Than HH; Mu O; Win AK; Singhasivanon P; White N; Nosten F
Antimicrob Agents Chemother; 2011 Dec; 55(12):5500-6. PubMed ID: 21947392
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of a co-formulated combination of amodiaquine and artesunate under fed and fasted conditions. A randomised, open-label crossover study.
Fitoussi S; Thang C; Lesauvage E; Barré J; Charron B; Filali-Ansary A; Lameyre V
Arzneimittelforschung; 2009; 59(7):370-6. PubMed ID: 19728565
[TBL] [Abstract][Full Text] [Related]
8. A small amount of fat does not affect piperaquine exposure in patients with malaria.
Annerberg A; Lwin KM; Lindegardh N; Khrutsawadchai S; Ashley E; Day NP; Singhasivanon P; Tarning J; White NJ; Nosten F
Antimicrob Agents Chemother; 2011 Sep; 55(9):3971-6. PubMed ID: 21709087
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
Tarning J; Rijken MJ; McGready R; Phyo AP; Hanpithakpong W; Day NP; White NJ; Nosten F; Lindegardh N
Antimicrob Agents Chemother; 2012 Apr; 56(4):1997-2007. PubMed ID: 22252822
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers.
Chotsiri P; Wattanakul T; Hoglund RM; Hanboonkunupakarn B; Pukrittayakamee S; Blessborn D; Jittamala P; White NJ; Day NPJ; Tarning J
Br J Clin Pharmacol; 2017 Dec; 83(12):2752-2766. PubMed ID: 28695570
[TBL] [Abstract][Full Text] [Related]
11. Effects of a high-fat meal on the relative oral bioavailability of piperaquine.
Sim IK; Davis TM; Ilett KF
Antimicrob Agents Chemother; 2005 Jun; 49(6):2407-11. PubMed ID: 15917540
[TBL] [Abstract][Full Text] [Related]
12. Sequential Open-Label Study of the Safety, Tolerability, and Pharmacokinetic Interactions between Dihydroartemisinin-Piperaquine and Mefloquine in Healthy Thai Adults.
Hanboonkunupakarn B; van der Pluijm RW; Hoglund R; Pukrittayakamee S; Winterberg M; Mukaka M; Waithira N; Chotivanich K; Singhasivanon P; White NJ; Dondorp AM; Tarning J; Jittamala P
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182525
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of piperaquine after repeated oral administration of the antimalarial combination CV8 in 12 healthy male subjects.
Röshammar D; Hai TN; Friberg Hietala S; Van Huong N; Ashton M
Eur J Clin Pharmacol; 2006 May; 62(5):335-41. PubMed ID: 16570188
[TBL] [Abstract][Full Text] [Related]
14. A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
Hoglund RM; Adam I; Hanpithakpong W; Ashton M; Lindegardh N; Day NP; White NJ; Nosten F; Tarning J
Malar J; 2012 Nov; 11():398. PubMed ID: 23190801
[TBL] [Abstract][Full Text] [Related]
15. Predicting the parasite killing effect of artemisinin combination therapy in a murine malaria model.
Patel K; Batty KT; Moore BR; Gibbons PL; Kirkpatrick CM
J Antimicrob Chemother; 2014 Aug; 69(8):2155-63. PubMed ID: 24777899
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of pregabalin controlled-release in healthy volunteers: effect of food in five single-dose, randomized, clinical pharmacology studies.
Chew ML; Plotka A; Alvey CW; Pitman VW; Alebic-Kolbah T; Scavone JM; Bockbrader HN
Clin Drug Investig; 2014 Sep; 34(9):617-26. PubMed ID: 25078976
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of the antimalarial drug piperaquine in healthy Vietnamese subjects.
Nguyen TC; Nguyen NQ; Nguyen XT; Bui D; Travers T; Edstein MD
Am J Trop Med Hyg; 2008 Oct; 79(4):620-3. PubMed ID: 18840754
[TBL] [Abstract][Full Text] [Related]
18. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
19. Reduced Exposure to Piperaquine, Compared to Adults, in Young Children Receiving Dihydroartemisinin-Piperaquine as Malaria Chemoprevention.
Whalen ME; Kajubi R; Chamankhah N; Huang L; Orukan F; Wallender E; Kamya MR; Dorsey G; Jagannathan P; Rosenthal PJ; Mwebaza N; Aweeka FT
Clin Pharmacol Ther; 2019 Dec; 106(6):1310-1318. PubMed ID: 31173649
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and bioequivalence evaluation of two fixed-dose tablet formulations of dihydroartemisinin and piperaquine in Vietnamese subjects.
Chinh NT; Quang NN; Thanh NX; Dai B; Geue JP; Addison RS; Travers T; Edstein MD
Antimicrob Agents Chemother; 2009 Feb; 53(2):828-31. PubMed ID: 19047656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
